APPLICATION
ANDA065291
TYPE
ANDA
ORIGINAL APPROVAL
2007-02-05
LATEST ACTION
2024-05-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
AMOXICILLINPrescription
AMOXICILLIN 250MG · CAPSULE · ORAL
AMOXICILLINPrescription
AMOXICILLIN 500MG · CAPSULE · ORAL
Approval history
2024-05-01Labeling · Supplement 33 · standardAP
2024-04-05Labeling · Supplement 32 · standardAP
2014-11-25Labeling · Supplement 9AP
2007-02-05OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.